肝酪氨酸转氨酶抑制剂会影响外源性酪氨酸的生物利用度。
Hepatic tyrosine aminotransferase inhibitor affects the bioavailability of exogenous tyrosine.
作者信息
Topall G, Laborit H
出版信息
Res Commun Chem Pathol Pharmacol. 1987 May;56(2):199-210.
PMID:2885906
Abstract
This study demonstrates the importance of controlling the activity of hepatic tyrosine aminotransferase when tyrosine is administered orally. The specific inhibition of this enzyme is proposed in the clinical use of tyrosine in syndromes related to deficient catecholaminergic transmission.
摘要
本研究证明了口服酪氨酸时控制肝脏酪氨酸转氨酶活性的重要性。在酪氨酸用于与儿茶酚胺能传递不足相关综合征的临床应用中，建议对该酶进行特异性抑制。
Zotero 插件